Nije utvr?ena bezbednost i efikasnost primene filgrastima kod pacijenata sa mijelodisplasti?nim sindromom ili hroni?nom mijeloidnom leukemijom.Because medical trials are performed less than broadly varying ailments, adverse reaction premiums observed during the clinical trials of the drug cannot be right compared with premiums within the medical tr